chr2-227055803-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000092.5(COL4A4):c.2716+142C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00286 in 742,898 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0092 ( 21 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 9 hom. )
Consequence
COL4A4
NM_000092.5 intron
NM_000092.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.217
Genes affected
COL4A4 (HGNC:2206): (collagen type IV alpha 4 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. This particular collagen IV subunit, however, is only found in a subset of basement membranes. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Mutations in this gene are associated with type II autosomal recessive Alport syndrome (hereditary glomerulonephropathy) and with familial benign hematuria (thin basement membrane disease). Two transcripts, differing only in their transcription start sites, have been identified for this gene and, as is common for collagen genes, multiple polyadenylation sites are found in the 3' UTR. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 2-227055803-G-C is Benign according to our data. Variant chr2-227055803-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 1214289.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-227055803-G-C is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00919 (1400/152272) while in subpopulation AFR AF = 0.0317 (1316/41540). AF 95% confidence interval is 0.0303. There are 21 homozygotes in GnomAd4. There are 682 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 21 SD gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00919 AC: 1399AN: 152154Hom.: 21 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1399
AN:
152154
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00122 AC: 722AN: 590626Hom.: 9 AF XY: 0.00109 AC XY: 342AN XY: 312494 show subpopulations
GnomAD4 exome
AF:
AC:
722
AN:
590626
Hom.:
AF XY:
AC XY:
342
AN XY:
312494
African (AFR)
AF:
AC:
466
AN:
15496
American (AMR)
AF:
AC:
47
AN:
24446
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
15026
East Asian (EAS)
AF:
AC:
0
AN:
34966
South Asian (SAS)
AF:
AC:
5
AN:
52592
European-Finnish (FIN)
AF:
AC:
0
AN:
42776
Middle Eastern (MID)
AF:
AC:
31
AN:
3604
European-Non Finnish (NFE)
AF:
AC:
86
AN:
370456
Other (OTH)
AF:
AC:
87
AN:
31264
Heterozygous variant carriers
0
35
70
106
141
176
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00919 AC: 1400AN: 152272Hom.: 21 Cov.: 32 AF XY: 0.00916 AC XY: 682AN XY: 74464 show subpopulations
GnomAD4 genome
AF:
AC:
1400
AN:
152272
Hom.:
Cov.:
32
AF XY:
AC XY:
682
AN XY:
74464
African (AFR)
AF:
AC:
1316
AN:
41540
American (AMR)
AF:
AC:
45
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5172
South Asian (SAS)
AF:
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
19
AN:
68018
Other (OTH)
AF:
AC:
19
AN:
2116
Heterozygous variant carriers
0
73
146
218
291
364
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jul 10, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at